CM Eddy, HE Rickards… - Therapeutic advances in …, 2011 - journals.sagepub.com
Effective treatment of epilepsy depends on medication compliance across a lifetime, and studies indicate that drug tolerability is a significant limiting factor in medication …
Impairments in cognition are common in epilepsy and may be caused or exacerbated by antiseizure medications (ASMs). Positive effects on cognition may also be seen with some …
SP Park, SH Kwon - Journal of clinical neurology (Seoul …, 2008 - synapse.koreamed.org
Patients with epilepsy often experience cognitive dysfunction. Multiple factors can adversely affect cognition in epilepsy, including the etiology of the seizures, cerebral lesions acquired …
B Martinc, I Grabnar, T Vovk - Current neuropharmacology, 2014 - ingentaconnect.com
Epilepsy is known as one of the most frequent neurological diseases, characterized by an enduring predisposition to generate epileptic seizures. Oxidative stress is believed to …
This article reviews the current position of phenobarbital using articles published since 2000 and speculates on its likely future contribution to epilepsy care. Over the last decade there …
PM Levisohn, M Mintz, SJ Hunter, H Yang, J Jones… - …, 2009 - Wiley Online Library
Purpose: Evaluate potential neurocognitive effects of adjunctive levetiracetam in children with inadequately controlled partial‐onset seizures (POS). Methods: Randomized, double …
KH Reeta, J Mehla, YK Gupta - European Journal of Pharmacology, 2010 - Elsevier
The antiepileptic drugs, phenobarbitone and carbamazepine are well known to cause cognitive impairment on chronic use. The increase in free radical generation has been …
AM Mahfoz, N Shahzad - Behavioural pharmacology, 2019 - journals.lww.com
Epilepsy is considered a major serious chronic neurological disorder, characterized by recurrent seizures. It is usually associated with a history of a lesion in the nervous system …